HomeCAPR • NASDAQ
add
Capricor Therapeutics Inc
Previous close
$5.64
Day range
$5.79 - $6.53
Year range
$2.68 - $8.22
Market cap
197.23M USD
Avg Volume
355.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 4.91M | 64.29% |
Operating expense | 15.17M | 332.29% |
Net income | -9.79M | -26.08% |
Net profit margin | -199.60 | 23.26% |
Earnings per share | -0.31 | 0.00% |
EBITDA | -10.00M | -25.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | -103.33% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -9.79M | -26.08% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2005
Headquarters
Website
Employees
102